In recent days, Recursion Pharmaceuticals announced a major leadership transition appointing Najat Khan, Ph.D., as CEO effective January 1, 2026, while also securing a milestone payment from Roche and ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

Abstract: Learning-based control has demonstrated great promise for handling complex tasks in various applications. However, ensuring system safety under uncertain dynamics remains a significant ...

The average retirement age in the U.S. is 62 — a figure that’s been rising since the 1990s. Many, or all, of the products featured on this page are from our advertising partners who compensate us when ...

A1： Join two tables and load data. A2： Use the switch function to modify the field values of the parent ticket to the record references of the parent ticket, and establish a self-associated ...

If you’ve ever met true geniuses, you probably already noticed that they don’t operate the way regular people do. It almost feels like people just know they’re smarter, doesn’t it? Truth be told, ...

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...

The company laid out its restructuring plans in a regulatory document. These include a workforce reduction of around 20%. Before market open, Recursion disclosed in a tersely worded regulatory filing ...

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027. Recursion ...

Patients are waiting an average of 31 days to schedule an appointment with a doctor, according to a study by AMN Healthcare of commonly used specialty physicians in 15 major U.S. cities. Patients ...

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported ...